schizandrin b has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pu, Z; Shen, C; Wang, W; Wang, X; Yin, Q; Zhang, W | 1 |
| Chen, H; Liu, W; Liu, Y; Lu, Q; Wang, Z; Yu, T | 1 |
2 other study(ies) available for schizandrin b and Colitis
| Article | Year |
|---|---|
Network pharmacology for systematic understanding of Schisandrin B reduces the epithelial cells injury of colitis through regulating pyroptosis by AMPK/Nrf2/NLRP3 inflammasome.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Colitis; Cyclooctanes; Epithelial Cells; HCT116 Cells; Humans; Inflammasomes; Lignans; Mice; Mice, Inbred C57BL; Mitochondria; Network Pharmacology; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Polycyclic Compounds; Pyroptosis | 2021 |
Suppression of MAPK and NF-κ B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cyclooctanes; Cytokines; Dextran Sulfate; Female; Inflammatory Bowel Diseases; Lignans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Polycyclic Compounds; Signal Transduction | 2015 |